000			02306 a2200613 4500
005			20250516053636.0
264		0	_c20120306
008			201203s 0 0 eng d
022			_a1873-5835
024	7		_a10.1016/j.leukres.2011.08.001 _2doi
040			_aNLM _beng _cNLM
100	1		_aTesfai, Yordanos
245	0	0	_aInteractions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy. _h[electronic resource]
260			_bLeukemia research _cMar 2012
300			_a299-306 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntigens, CD34 _xmetabolism
650	0	4	_aAntimetabolites, Antineoplastic _xpharmacology
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aAntineoplastic Agents, Hormonal _xpharmacology
650	0	4	_aAntineoplastic Agents, Phytogenic _xpharmacology
650	0	4	_aAsparaginase _xpharmacology
650	0	4	_aBiomarkers, Tumor _xgenetics
650	0	4	_aBone Marrow Cells _xdrug effects
650	0	4	_aCase-Control Studies
650	0	4	_aCell Communication _xdrug effects
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aChild
650	0	4	_aCohort Studies
650	0	4	_aCytarabine _xpharmacology
650	0	4	_aDexamethasone _xpharmacology
650	0	4	_aGene Expression Profiling
650	0	4	_aHumans
650	0	4	_aNeoplasm Staging
650	0	4	_aOligonucleotide Array Sequence Analysis
650	0	4	_aPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy
650	0	4	_aPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy
650	0	4	_aPrincipal Component Analysis
650	0	4	_aPrognosis
650	0	4	_aRNA, Messenger _xgenetics
650	0	4	_aReal-Time Polymerase Chain Reaction
650	0	4	_aStromal Cells _xdrug effects
650	0	4	_aVincristine _xpharmacology
700	1		_aFord, Jette
700	1		_aCarter, Kim W
700	1		_aFirth, Martin J
700	1		_aO'Leary, Rebecca A
700	1		_aGottardo, Nicholas G
700	1		_aCole, Catherine
700	1		_aKees, Ursula R
773	0		_tLeukemia research _gvol. 36 _gno. 3 _gp. 299-306
856	4	0	_uhttps://doi.org/10.1016/j.leukres.2011.08.001 _zAvailable from publisher's website
999			_c21131432 _d21131432